How Many People Have a Lazy Eye (Amblyopia)?

Roughly 1 in 70 people worldwide has amblyopia, commonly called a lazy eye. Two large meta-analyses put the global prevalence between about 1.4% and 1.5%, which translated to an estimated 99 million people living with the condition in 2019. That number is expected to climb as the global population ages and grows, with projections reaching over 220 million by 2040. The condition is far more common than most people assume, and its prevalence shifts depending on where you live, your age, and how the diagnosis is defined.

The Global Numbers

Two systematic reviews and meta-analyses provide the most reliable worldwide estimates, and they agree closely. One, pooling 97 studies covering over 4.6 million children, found an overall prevalence of about 1.4% in children globally.¹ The other, drawing on 60 studies and nearly 1.9 million subjects of all ages, arrived at a very similar pooled rate of about 1.4%.² What stands out in the second analysis is that the highest prevalence appeared in people over 20 years old, at about 3.3%. That finding is somewhat counterintuitive since amblyopia develops in childhood, but it reflects the fact that many cases go undetected or untreated and persist into adulthood.

The projections are striking. The 2019 estimate of roughly 99 million cases worldwide is expected to jump to around 175 million by 2030 and roughly 222 million by 2040.² Those increases are driven less by rising rates of the condition itself and more by population growth and longer life expectancy, which means more people carry their childhood amblyopia into old age.

Why Prevalence Varies So Much by Region

Amblyopia is not evenly distributed around the world. Europe shows the highest regional prevalence at about 2.9%, followed by North America at about 2.4%. Asia comes in around 1.1%, and Africa is lowest at roughly 0.7%.² These gaps are real, but they need context. Access to screening affects how many cases get counted. A country with universal preschool vision checks will identify mild amblyopia that might go unnoticed in a country without such programs. That means Africa’s lower figure could partly reflect underdiagnosis rather than genuinely lower risk.

Ethnic and racial differences appear even within the same country. A multi-ethnic study of school-aged children across several countries found that Hispanic children had the highest prevalence at about 1.4%, followed by Chinese children at roughly 0.9%, Indian children at 0.6%, Malay children at 0.5%, Nepali children at 0.4%, and African children at about 0.3%.³ U.S.-based studies tell a similar story. The Multi-ethnic Pediatric Eye Disease Study found amblyopia in about 2.6% of Hispanic/Latino children and 1.5% of African American children, and roughly 78% of those cases were caused by refractive error rather than eye misalignment.⁴ The Baltimore Pediatric Eye Disease Study found White children had a prevalence of about 1.8% versus 0.8% in African American children, though the sample sizes were small enough that the difference did not reach statistical significance.⁵

As for sex differences, the picture is mixed. The children-focused meta-analysis found boys had a slightly higher prevalence than girls (about 1.4% versus 1.2%).¹ The broader meta-analysis covering all ages found no difference between genders.² If there is a real gap, it is small enough that individual studies frequently fail to detect it.

What Causes Amblyopia in the First Place

Amblyopia is not actually a problem with the eye itself. It is a brain problem. During early childhood, the visual system wires itself based on the signals it receives. If one eye sends the brain a consistently blurrier or misaligned image, the brain gradually learns to suppress that eye’s input. Over time, the neural pathways serving that eye weaken, and the eye’s visual acuity drops even though the eye’s physical structures are often perfectly healthy. The brain has essentially “chosen” to rely more on the other eye.

The underlying causes that trigger this process fall into a few categories. The most common is anisometropia, where one eye has a significantly different refractive error than the other (for example, one eye is much more farsighted). Studies consistently find this accounts for roughly 45% to 50% of amblyopia cases.⁶⁷ Strabismus, where the eyes are physically misaligned (one eye turns inward, outward, or vertically), accounts for roughly 13% to 19% on its own. A mixed category combining both strabismus and anisometropia represents another 17% to 27%. Visual deprivation, caused by conditions like a congenital cataract or a droopy eyelid physically blocking vision, accounts for only about 4% of cases but tends to be the most severe.⁶

This distribution matters because it affects detection. A child with strabismus may have a visibly crossed or wandering eye that a parent notices. A child with anisometropia, on the other hand, often shows no outward sign at all. The child may not even realize anything is wrong because the “good” eye compensates seamlessly. That is why screening programs focus heavily on identifying refractive differences between the two eyes.

Family History and Other Risk Factors

Amblyopia clusters in families, though the genetics are not straightforward. In a study of 341 children with amblyopia, about 8% had a first-degree relative who also had the condition. The rate of family history was highest among children whose amblyopia involved strabismus (about 16% had a relative affected) and lower in cases of purely refractive amblyopia (about 5%).⁸ Premature birth and time spent in neonatal intensive care also appeared as risk factors across the amblyopia subtypes in that same study. These are not surprising associations: prematurity is already linked to a range of visual development issues, and strabismus itself has a strong hereditary component.

Does Screening Actually Help

Catching amblyopia early is the whole game, because treatment works best when the visual system is still developing. A systematic review of preschool screening programs found that screening was associated with a reduction of roughly 0.9 to 1.6 percentage points in the prevalence of amblyopia later on, translating to a relative reduction of about 45% to 62%.⁹ Those are substantial numbers, but the review also noted that the studies had real limitations, including small sample sizes and inconsistent follow-up. A separate economic review concluded that vision screening for young children is likely cost-effective compared with no screening, provided amblyopia genuinely reduces quality of life, which the evidence on daily functioning strongly suggests it does.¹⁰

Many countries and U.S. states now recommend vision screening at ages 3 to 5, but the quality and frequency vary enormously. In places without systematic screening, children with refractive amblyopia in particular may reach school age or even adulthood without anyone knowing they cannot see clearly out of one eye.

How Amblyopia Affects Everyday Life

The most consistent functional problem is impaired depth perception. Stereoscopic vision, the ability to perceive depth from the slight difference in the images each eye sends to the brain, is often substantially reduced or absent in people with amblyopia.¹¹ This affects tasks that most people do without thinking: catching a ball, pouring liquid into a container, navigating stairs, threading a needle, parking a car. For children, it can make sports frustrating. For older adults, it can make falls more likely. Strabismic amblyopia tends to impair stereopsis more severely than anisometropic amblyopia.

Beyond depth perception, qualitative studies of adults living with amblyopia reveal a range of daily impacts that often go unrecognized. In one study, adults described limitations in driving, reading, and mobility. Many reported anxiety about losing vision in their “good” eye, since they knew they had no backup. Negative emotions like grief and disappointment over childhood eye care that failed them or that they had not complied with came up repeatedly. Some participants reported that career choices had been compromised because certain professions require binocular vision for licensing.¹² Another study covering both adults and children found that amblyopia affected reading, digital device use, productivity at work or school, emotional well-being, and socializing.¹³

A systematic review of quality-of-life research found that the biggest quality-of-life burden for children came not from the amblyopia itself but from its treatment. Patching and other therapies disrupted family life, social interactions, and school activities, sometimes leading parents and children to reduce or abandon treatment.¹⁴ That creates a painful tension: the treatment that works best for the eye can feel worst for the child.

Patching, Drops, and the Compliance Problem

The standard treatment for amblyopia is to force the brain to use the weaker eye. Traditionally, this means placing an adhesive patch over the stronger eye for several hours a day. In a randomized trial of children aged 7 to 12, patching improved vision in the amblyopic eye by an average of about 8.6 letters on a vision chart over 17 weeks.¹⁵ A trial in younger children found that about 79% of the patching group achieved either 20/30 vision or an improvement of three or more lines on a vision chart after six months.¹⁶

Atropine eye drops offer an alternative. When placed in the stronger eye, atropine blurs its near vision, giving the weaker eye a competitive advantage. Head-to-head trials have found that atropine and patching produce similar improvements. In the trial of 7- to 12-year-olds, atropine improved acuity by about 7.6 letters compared with the 8.6 from patching, a difference the researchers considered clinically equivalent.¹⁵ Another trial in older children with anisometropic amblyopia found essentially identical improvements (about 2.3 lines) in both groups at six months, though patching worked faster.¹⁷ Parents and children tend to find atropine more acceptable than patching, which makes sense: a drop in the morning is less conspicuous and less socially awkward for a school-age child than a patch worn for hours.

Compliance is the Achilles’ heel of patching therapy. A qualitative study of parents found that many described real distress in their children, particularly early on. Parents were sensitive to whether the treatment was actually working, and if they could not see improvement or if their child was suffering socially or educationally, many modified or dropped the treatment on their own.¹⁸ The study noted that simply giving parents more information was not enough; what they needed was practical support and reassurance that the treatment was making a difference. A recent meta-analysis comparing patching to dichoptic therapy (described below) found that skin irritation was the most common adverse event with patching, adding a physical complaint on top of the social and emotional ones.¹⁹

Video Games, VR, and Newer Approaches

The logic behind newer treatments is different from patching. Rather than shutting down the strong eye entirely, dichoptic therapy shows different images to each eye simultaneously, with the image presented to the strong eye at reduced contrast. The idea is to get the brain to use both eyes together, rebalancing the input rather than just penalizing the dominant side. Preliminary research suggests this approach leads to lasting improvements in visual acuity and may serve as either an alternative or a supplement to conventional patching.²⁰

One concrete version of this uses action video games. In a feasibility study with 21 children, those who played an action game dichoptically (with reduced contrast to the fellow eye) improved their visual acuity by about 38%, compared with about 15% for children who played the same game monocularly with the good eye patched. Depth perception also improved more in the dichoptic group.²¹ That study was small and short-term, so the results need to be taken cautiously, but the basic finding, that engaging both eyes through a game could outperform patching alone, has generated real excitement. Virtual reality platforms using the same dichoptic principle are also being designed and tested.²²

That said, a meta-analysis comparing dichoptic therapy to patching across randomized trials found that traditional patching still produced somewhat larger improvements in visual acuity overall, with a small but statistically significant edge.¹⁹ The promise of dichoptic therapy may lie not in replacing patching but in reaching patients who would not tolerate patching well enough for it to work.

Can Adults Still Improve

The conventional wisdom for decades was that amblyopia treatment only works during a “critical period” in early childhood, and that once that window closes, the brain is essentially locked in. There is real biology behind this idea: research has shown that the brain actively puts the brakes on visual plasticity as it matures, rather than simply losing the ability to change.²³ Animal studies have even identified specific molecular “brakes” in the visual cortex that restrict change after the critical period. In mice, manipulating certain genes in excitatory neurons or in the thalamus allowed recovery of visual acuity even after prolonged deprivation, suggesting the brain retains latent capacity for change that is normally held in check.²⁴

In humans, growing evidence suggests the adult visual system retains more plasticity than previously believed. An evidence-based review concluded that the plasticity of the adult visual system can be harnessed to achieve gains in visual acuity, and that dichoptic training in particular is promising because it engages both eyes simultaneously.²⁵ A small proof-of-concept study demonstrated that three adult amblyopes who trained on a specialized “push-pull” protocol gained long-lasting improvements in both the balance between their eyes and their depth perception.²⁶ The improvements were described as longstanding, not transient.

Realistically, adult treatment is still early-stage. The gains tend to be smaller and slower than what children achieve, and the evidence comes mostly from small studies and proof-of-concept work rather than large trials. But the shift in thinking is significant. Telling an adult “nothing can be done” is no longer entirely accurate. If you are an adult with amblyopia and you are motivated to try, there are increasingly real options to discuss with a specialist, though expectations should be modest.

The Fellow Eye Problem

One underappreciated concern for people with amblyopia is what happens if they lose vision in their good eye. Because the amblyopic eye never fully developed its neural connections, it cannot simply take over the way a normal eye would. An injury, disease, or even age-related macular degeneration in the dominant eye could leave someone with profoundly limited vision rather than merely reduced vision. This worry is not theoretical: qualitative studies have found that adults with amblyopia frequently report anxiety about the safety of their better eye, living with a persistent background fear that they are one accident away from serious visual disability.¹² This vulnerability is one reason eye care professionals take amblyopia seriously even when it is mild. The condition removes the safety net of having two independently functional eyes.

1
PubMed Central. The Global Prevalence of Amblyopia in Children: A Systematic Review and Meta-Analysis
2
PubMed. Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis
3
PubMed Central. Prevalence of Amblyopia in School-Aged Children and Variations by Age, Gender, and Ethnicity in a Multi-Country Refractive Error Study
4
PubMed Central. Prevalence of Amblyopia and Strabismus in African American and Hispanic Children Ages 6 to 72 Months: The Multi-ethnic Pediatric Eye Disease Study
5
PubMed Central. Prevalence of Amblyopia and Strabismus in White and African-American Children Aged 6 through 71 Months: The Baltimore Pediatric Eye Disease Study
6
PubMed. Prevalence and causes of amblyopia in an adult population
7
PubMed. The Prevalence of Amblyopia and Its Determinants in a Population-based Study
8
Namik Kemal Medical Journal. Clinical Characteristics and Risk Factors of Patients with Pediatric Amblyopia
9
PubMed Central. Effectiveness of screening preschool children for amblyopia: a systematic review
10
PubMed Central. Economic evaluations of vision screening to detect amblyopia and refractive errors in children: a systematic review
11
PubMed Central. Stereopsis and amblyopia: A mini-review
12
PubMed. Does non-strabismic amblyopia affect the quality of life of adults? Findings from a qualitative study
13
PubMed Central. Qualitative Exploration of the Visual Function Impairments and Health-Related Quality of Life Impacts of Amblyopia in Adult and Pediatric Populations
14
PubMed Central. Amblyopia and quality of life: a systematic review
15
PubMed Central. Patching vs Atropine to Treat Amblyopia in Children Aged 7 to 12 Years: A Randomized Trial
16
JAMA Ophthalmology. A Randomized Trial of Atropine vs Patching for Treatment of Moderate Amblyopia in Children
17
PubMed. Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children
18
Archives of Disease in Childhood. Why is compliance with occlusion therapy for amblyopia so hard? A qualitative study
19
PubMed Central. Efficacy of Dichoptic Treatment vs Eye Patching in Pediatric Patients with Amblyopia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
20
PubMed Central. Binocular vision therapy for the treatment of Amblyopia-A review
21
PubMed Central. An action video game for the treatment of amblyopia in children: A feasibility study
22
PubMed Central. Design and assessment of amblyopia, strabismus, and myopia treatment and vision training using virtual reality
23
PubMed Central. Critical periods in amblyopia
24
Current Biology. Plasticity of Eye Dominance and Acuity Are Independently Restricted in Mammalian Visual Circuitry
25
PubMed Central. Harnessing brain plasticity to improve binocular vision in amblyopia: An evidence-based update
26
Current Biology. A push-pull treatment for strengthening the ‘lazy eye’ in amblyopia